A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease

BACKGROUND: Biochemical markers for liver fibrosis (FibroTest) and necroinflammatory features (ActiTest) are an alternative to liver biopsy in patients with chronic hepatitis C. Our aim was to assess the inter-laboratory variability of these tests, and their 6 components (γ-glutamyl transpeptidase,...

Descripción completa

Detalles Bibliográficos
Autores principales: Halfon, Philippe, Imbert-Bismut, Françoise, Messous, Djamila, Antoniotti, Gilles, Benchetrit, Didier, Cart-Lamy, Philippe, Delaporte, Gilles, Doutheau, Danièle, Klump, Théo, Sala, Michel, Thibaud, Didier, Trepo, Elisabeth, Thabut, Dominique, Myers, Robert P, Poynard, Thierry
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149429/
https://www.ncbi.nlm.nih.gov/pubmed/12537583
http://dx.doi.org/10.1186/1476-5926-1-3

Ejemplares similares

Ejemplares similares